Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Parathyroid Hormone (PTH) and Alendronate in Combination in the Treatment of Osteoporosis

NCT00005005 is registered in ClinicalTrials.gov with Dennis Black as lead sponsor.

NCT NCT00005005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Parathyroid Hormone (PTH) and Alendronate in Combination in the Treatment of Osteoporosis
Lead sponsor
Dennis Black
Phase
Phase 2
Overall status
Completed
Start date
October 31, 1999
Completion date
November 30, 2007
Enrollment
238 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis